Vista AI Scan
Vista AI, Inc. · Decision date Oct 7, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the Vista AI Scan, a premarket notification submitted by Vista AI, Inc. of Palo Alto, California. The record lists the device under classification name System, Nuclear Magnetic Resonance Imaging, regulation 892.1000, product code LNH, with Radiology as the medical specialty and review panel. The application is K260092, received 01/12/2026 and decided 10/07/2026; the same decision appears in the agency's final-decision listing dated 07 Oct 2026.
SESE denotes 510(k) clearance rather than PMA approval, and the record identifies the submission type as Traditional, not reviewed by a third party, and not a combination product. A Predetermined Change Control Plan is marked as authorized. The public record does not describe the specific components, software functions or changed items covered, and no summary statement is included here; those details would need to come from the linked FDA summary document.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 7, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260092
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Vista AI, Inc.
- Product code
- LNH
- Decision code
- SESE
- Decision date
- Oct 7, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Nuclear Magnetic Resonance Imaging.
- Applicant
- Vista AI, Inc.
- Product code
- LNH
- FDA device class
- 2
FDA decision timeline
K260092 received
Application receipt date recorded by FDA.
K260092 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LNH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MAGNETOM Free.XLK262011 | Siemens Healthineers AG | 510(k) clearance | Nov 5, 2026 | FDA |
ECHELON SynergyK262902 | Fujifilm Corporation | 510(k) clearance | Oct 9, 2026 | FDA |
SwiftSight-BodyCompositionK261612 | Airs Medical, Inc. | 510(k) clearance | Oct 1, 2026 | FDA |
APERTO Lucent MRI SystemK261283 | Fujifilm Corporation | 510(k) clearance | Sep 16, 2026 | FDA |
| Aspect Imaging, Ltd. | 510(k) clearance | Sep 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Vista AI, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Palo Alto, CA
Sources and methodology
- Original FDA record: K260092
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

